- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01226433
Family Planning Through Dairy Cooperatives
Providing Family Planning Services Sustainably Through Dairy Cooperatives in Kenya
Studieoversigt
Status
Detaljeret beskrivelse
Access to family planning and other reproductive health services remains difficult in much of rural Kenya. One option for improving rural access to family planning is to use existing community events outside of the health sector as platforms for delivering information and services. This study will assess a model for providing family planning through quarterly events organized by dairy cooperatives supported by Land O'Lakes in Kenya. During these events, known as Field Days, a healthcare provider will have a tent in which Field Day attendees can receive basic family health services free of charge. The services offered will be: family planning counseling and methods, immunizations, antenatal care, screening and treatment for sexually transmitted infections, and HIV counseling and testing. Since the services are no different than those that could be obtained at Ministry of Health or some private facilities, the service provision is not considered to be part of the research.
Women receiving any service from the health care provider will be recruited for an interview that will measure their demand for family planning and attitudes about receiving services during the field day. In addition, the study will track the number of different types of services provided, the total number of Field Day attendees, and the cost of the service model. The study will be carried out at five Field Days in Rift Valley and Central provinces.
Participants will not be tested for STI/HIV as part of this research; however, at their request, they may have received a test from the provider prior to the research interview. At the time of consent, they will have already received the test, so the consent form will not include anything specific to testing. In Kenya, all STI/HIV test results are reported to the national public health authorities. These reports are not used for contacting patients but for planning purposes.
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
Rift Valley & Central
-
Various, Rift Valley & Central, Kenya
- 5 Community Outreach Events
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:females aged 18-49 receiving health services at a field day event -
Exclusion Criteria:
-
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Health Services Research
Tidsramme: 1 year
|
Unmet need for family planning among women attending Field Days aged 18-49
|
1 year
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Health Services Research
Tidsramme: 1 year
|
Interest in receiving health services through Field Day model
|
1 year
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: John Bratt, MPP, MA, FHI 360
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
- AE uønsket hændelse
- AIDS erhvervet immundefekt syndrom
- ALT (SGPT) alaninaminotransferase
- ART antiretroviral behandling
- AST (SGOT) aspartataminotransferase
- DCF dataindsamlingsskemaer
- DMC Dataovervågningsudvalg
- FDA (U.S.) Food and Drug Administration
- GCP retningslinjer for god klinisk praksis
- HB sAg Hepatitis B overfladeantigen
- ICH International Conference of Harmonization
- IND Investigational New Drug Application
- IRB Institutional Review Board
- IU internationale enheder
- mg milligram(er)
- mm3 kubikmillimeter(r)
- PCR polymerase kædereaktion
- SAE alvorlig uønsket hændelse
- µg mikrogram
- ULN øvre grænse for normalområdet
- WB Western Blot
Andre undersøgelses-id-numre
- 10227
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .